AbbVie is a global, research-based biopharmaceutical company with a mission to use the expertise of dedicated people and a unique approach to innovation to develop advanced therapies that address some of the world's most complex and serious diseases. The Postdoctoral Program is designed for true investigational and experimental research. Participants will be mentored by renowned industry scientists and collaborators at AbbVie and will be focused on delivering cutting-edge advancements in discovery. The enriching training program offers a balance of structured learning and work experience which fosters a learning environment to advance individual development with accessibility to high-level knowledge building across the drug development continuum.
To be successful, we need outstanding individuals willing to challenge themselves to find the best solutions for our patients. The AbbVie Postdoctoral Program is one way we are doing just that. Through our Postdoctoral Program, we are hiring postdocs from key academic institutions for preferred areas of science in the U.S., while providing a unique opportunity for participants to build a solid career foundation in the pharmaceutical industry and building the AbbVie brand as an employer of choice for scientific talent. Participants in the Postdoctoral Program play an integral part in our continued success and will help us to further grow as a leader in our industry. The successful candidate will conduct novel and impactful research over a 2-3-year period. High-impact publications and presentations at scientific meetings are expected outcomes along with the opportunity to gain valuable experience working within a top-tier biopharmaceutical company. This assignment is expected to be for two years minimally and no more than three years.
AbbVie has established the Foundational Neuroscience Center (FNC) in Cambridge, MA to investigate the fundamental biological mechanisms and to develop therapeutic interventions for neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases. Although it is widely understood that Alzheimer’s disease (AD) primarily affects neurons of the hippocampus and cortex, the mechanism underlying the selective vulnerability of these neurons to tau pathology remains unclear. Stem cell technology offers the ability to convert stem cells from a single donor line into highly pure populations of different neuron subtypes representing both affected and unaffected neurons in AD. The Tau Biology group is seeking a highly motivated applicant with prior experience and expertise in cell biology and molecular neuroscience to leverage stem cell technology to test susceptibility to tau aggregation and to uncover the molecular signature characterizing vulnerability in a disease-relevant system. The aim of this project is to differentiate human induced pluripotent stem cells (iPSC) into neurons expressing markers of the forebrain, midbrain, hindbrain or peripheral nervous system, evaluate those neurons in our tau aggregation assay, and investigate mechanisms that underly the unique properties of each neuron subtype.
About AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
View WebsiteGet More Interviews for This and Many Other Jobs
Huntr helps you instantly craft tailored resumes and cover letters, fill out application forms with a single click, effortlessly keep your job hunt organized, and much more.
Sign Up for Free